Obesity and risk of malignant melanoma: A meta-analysis of cohort and case–control studies
Introduction
The epidemiology of malignant melanoma (hereafter called melanoma) has followed a long trajectory, starting with the sunlight hypothesis in the ’50s1; the current palette of risk factors essentially encompasses exogenous parameters, among which sun exposure and its correlates represent the primary cornerstone,1, 2 as well as inherent features, such as skin-eye-hair colour, family history,3 presence of common or atypical naevi,4 immunosuppression5 or even novel genetic loci.6 The attempts envisaging a link between melanoma and oral contraceptive use have not proven fruitful.7
Obesity is a well established risk factor for several cancer types8; noticeably, it has been postulated that obesity may account for approximately 20% of all cancer cases.9 The spectrum of obesity-related cancer may span, among other types, colon,10 endometrial,11 postmenopausal breast,9 renal,8, 9 oesophageal,8 thyroid,8, 9 prostate12 and possibly some haematologic malignancies.13
Regarding melanoma, a possible association with obesity remains rather unclear at the meta-analytical level, whereas individual studies have yielded mutually conflicting results. So far, two pooling approaches have appeared in the literature. Renehan et al. performed a meta-analysis especially on prospective (cohort) studies and found elevated melanoma risk with increasing body mass index (BMI) among men.8 On the other hand, Olsen et al. pooled eight case–control studies exclusively conducted on women; their results suggested a null association between BMI or body surface area (BSA) and melanoma risk.14 To our knowledge, no effort has been undertaken till now, aiming to synthesise all published cohort and case–control studies, in order to evaluate the association between melanoma and obesity.
To this end, our aim was to comprehensively examine the association between obesity and melanoma risk, synthesising all available evidence. Two indices have been assessed as markers of obesity, according to the individual studies i.e. BMI and BSA. Separate analyses were undertaken in males and females, so as to uncover sex-specific differences, if any.
Section snippets
Search terms, eligibility and exclusion criteria
This meta-analysis was conducted in accordance with the Meta-analysis Of Observational Studies in Epidemiology (MOOSE) guidelines.15 Following a combined computerised and manual systematic database search of medical literature, potentially informative publications were retrieved from electronic search engines (Medline, Scopus, Google Scholar, Ovid and the Cochrane Library). Reference lists were thereafter systematically searched for relevant articles.
Eligible articles included case–control and
Characteristics of eligible studies
As shown in the flow diagram (Fig. 1), a total of 31,619 abstracts were identified and screened. After exclusion of the 31,584 irrelevant abstracts, 10 articles had been performed on mutually overlapping populations. In particular, the article by Odenbro et al.23 overlapped with the article by Samanic et al.,24 while the article by Naldi et al.25 overlapped with the eligible article by Gallus et al.26; in addition, eight articles27, 28, 29, 30, 31, 32, 33, 34 were excluded as they totally
Association of BMI and risk for melanoma among males
Compared with a BMI < 25 kg/m2, the pooled effect estimate for overweight males was 1.31 (95% CI: 1.18–1.45, fixed effects, Fig. 2a); similarly, the pooled effect estimate for obese males was 1.31 (95% CI: 1.19–1.44, fixed effects, Fig. 2b). Of note, the pooled estimates were practically equal regarding overweight and obese males, pointing to the existence of an underlying plateau. The positive association for both obese and overweight males was reproducible in the subsets of case–control and cohort
Discussion
The current meta-analysis, comprising both case–control and cohort studies and using two indices of obesity, showed increased melanoma risk of the same magnitude for overweight and obese males. By contrast, regarding females, the overall meta-analysis and meta-regression analysis pointed to a null association between obesity and melanoma risk. Confounding between sunlight exposure and obesity among females seemed to be a plausible underlying factor for these apparently contradictory results.
Conflict of interest statement
None declared.
Acknowledgements
We would like to thank Dr. Evangelos Evangelou, University of Ioannina, for his kind advice at the initial stage of the analysis. We would like to express our gratitude to the following colleagues, who kindly provided us with valuable data on their studies: Dr. Diane Feskanich, Dr. Silvano Gallus, Dr. Amy E. Millen, Dr. Pär Stattin and Dr. Marco Vinceti. This research has been funded in part by the Athens University Medical School. This work was supported by Karolinska Institutet, Distinguished
References (65)
- et al.
Meta-analysis of risk factors for cutaneous melanoma: III. Family history, actinic damage and phenotypic factors
Eur J Cancer
(2005) - et al.
Meta-analysis of risk factors for cutaneous melanoma: I. Common and atypical naevi
Eur J Cancer
(2005) - et al.
Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies
Lancet
(2008) - et al.
Body mass index and incidence of localized and advanced prostate cancer – a dose-response meta-analysis of prospective studies
Ann Oncol
(2012) - et al.
Cutaneous melanoma and obesity in the Agricultural Health Study
Ann Epidemiol
(2008) - et al.
Obesity and cancer risk: a Danish record-linkage study
Eur J Cancer
(1994) - et al.
Melanoma risk in association with serum leptin levels and lifestyle parameters: a case–control study
Ann Oncol
(2008) - et al.
Diet and melanoma. An exploratory case–control study
Ann Epidemiol
(1993) - et al.
Obesity and cancer risk: the role of the insulin-IGF axis
Trends Endocrinol Metab
(2006) - et al.
Systematic reviewers commonly contact study authors but do so with limited rigor
J Clin Epidemiol
(2009)
Textbook of cancer epidemiology
Biologic markers of sun exposure and melanoma risk in women: pooled case–control analysis
Int J Cancer
Cancer incidence before and after kidney transplantation
JAMA
Comprehensive field synopsis and systematic meta-analyses of genetic association studies in cutaneous melanoma
J Natl Cancer Inst
A pooled analysis of 10 case–control studies of melanoma and oral contraceptive use
Br J Cancer
Obesity and cancer
Oncologist
A quantitative analysis of body mass index and colorectal cancer: findings from 56 observational studies
Obes Rev
Body mass index, hormone replacement therapy, and endometrial cancer risk: a meta-analysis
Cancer Epidemiol Biomarkers Prev
Obesity and the risk for a hematological malignancy: leukemia, lymphoma, or myeloma
Oncologist
Anthropometric factors and risk of melanoma in women: a pooled analysis
Int J Cancer
Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group
JAMA
Aspirin use and breast cancer risk: a meta-analysis and meta-regression of observational studies from 2001 to 2005
Pharmacoepidemiol Drug Saf
Maternal smoking during pregnancy and childhood lymphoma: a meta-analysis
Int J Cancer
Meta-analysis of epidemiologic dose–response data
Epidemiology
Choice of exposure scores for categorical regression in meta-analysis: a case study of a common problem
Cancer Causes Control
Bias in meta-analysis detected by a simple, graphical test
BMJ
Improved tests for a random effects meta-regression with a single covariate
Stat Med
The risk for cutaneous malignant melanoma, melanoma in situ and intraocular malignant melanoma in relation to tobacco use and body mass index
Br J Dermatol
Relation of body mass index to cancer risk in 362,552 Swedish men
Cancer Causes Control
Risk of melanoma and vitamin A, coffee and alcohol: a case–control study from Italy
Eur J Cancer Prev
Anthropometric measures and risk of cutaneous malignant melanoma: a case–control study from Italy
Melanoma Res
Cited by (132)
Multifaceted effects of obesity on cancer immunotherapies: Bridging preclinical models and clinical data
2023, Seminars in Cancer BiologyAdiposity and sex-specific cancer risk
2023, Cancer CellAdipocyte Extracellular Vesicles Decrease p16<sup>INK4A</sup> in Melanoma: An Additional Link between Obesity and Cancer
2022, Journal of Investigative DermatologyAssociation between Obesity and Sunburn Diagnoses: A Cross-Sectional Analysis in a Large Claims Dataset
2022, Journal of Investigative Dermatology